Valence (VLNC) Gets HQ Appeal Dismissed Over Lithium Metal Phosphate Tech Patent
Up)
Valence Technology, Inc. (Nasdaq: VLNC), has prevailed in seeking the dismissal of an appeal by Hydro-Quebec (HQ) of a decision of the European Patent Office revoking a HQ European patent. The EPO Patent corresponded to the primary HQ patent being litigated in the Western District of Texas Federal Court (Austin). The patent is related to lithium metal phosphate technology.
Valence had challenged the grant of European Patent number 0904607, originally held by the University of Texas and now assigned to HQ, in an opposition proceeding in the European Patent Office filed on July 27, 2005. In December 2008, the EPO Opposition Board revoked the grant of the patent based on evidence presented by Valence showing that the patent lacked novelty. The Board's decision revoking HQ's European Patent eliminated any risk that HQ could assert the European Patent against Valence's proprietary lithium iron magnesium phosphate cathode material, a critical material for the next generation of advanced batteries. HQ filed an appeal of the 2008 revocation of the European Patent. The appeal hearing was heard and decided on February 2, 2012, by an EPO Board of Appeal, which dismissed HQ's appeal. As a result of the decision, European Patent number 0904607 has been revoked by the EPO in its entirety. Valence was represented in the opposition and the appeal by Dr. Claus Beckmann of the German Intellectual Property Law firm Kraus & Weisert.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
Valence had challenged the grant of European Patent number 0904607, originally held by the University of Texas and now assigned to HQ, in an opposition proceeding in the European Patent Office filed on July 27, 2005. In December 2008, the EPO Opposition Board revoked the grant of the patent based on evidence presented by Valence showing that the patent lacked novelty. The Board's decision revoking HQ's European Patent eliminated any risk that HQ could assert the European Patent against Valence's proprietary lithium iron magnesium phosphate cathode material, a critical material for the next generation of advanced batteries. HQ filed an appeal of the 2008 revocation of the European Patent. The appeal hearing was heard and decided on February 2, 2012, by an EPO Board of Appeal, which dismissed HQ's appeal. As a result of the decision, European Patent number 0904607 has been revoked by the EPO in its entirety. Valence was represented in the opposition and the appeal by Dr. Claus Beckmann of the German Intellectual Property Law firm Kraus & Weisert.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- Syngenta (SYT) settles atrazine litigation; will pay $105M in deal
- EU Wants to Settle Antitrust Issues as Much as Google (GOOG), It Just Needs Proof
- Auxilium (AUXL) Files Suit Against Watson (WPI) Over Testim 1% Gel
Create E-mail Alert Related Categories
Corporate News, LitigationSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
